Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
China Healthwise HoldingsHKSE:00348 -6.12% Days Payable is 59.75 as of Dec. 2025, which is 23% below its 10-year median of 77.14. The stock has 3 warning signs investors should review. Among 609 Healthcare Providers & Services companies, China Healthwise Holdings ranks better than 58.78% on this metric.
The historical rank and industry rank for China Healthwise Holdings's Days Payable or its related term are showing as below:
HKSE:00348'
s Days Payable Range Over the Past 10 Years
Min: 44.53 Med: 77.14 Max: 118.83
Current: 71.31
During the past 13 years, China Healthwise Holdings's highest Days Payable was 118.83. The lowest was 44.53. And the median was 77.14.
HKSE:00348's Days Payable is ranked better than 58.78% of 609
companies
in the Healthcare Providers & Services industry
Industry Median: 57.13
vs HKSE:00348: 71.31
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Healthwise Holdings Days Payable Competitor Comparison
For the Pharmaceutical Retailers subindustry, China Healthwise Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Healthwise Holdings Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, China Healthwise Holdings's Days Payable distribution charts can be found below:
* The bar in red indicates where China Healthwise Holdings's Days Payable falls into.
China Healthwise Holdings Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
China Healthwise Holdings's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Healthwise Holdings (HKSE:00348) has a Days Payable of 59.75 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on China Healthwise Holdings and its competitors. This is 23% below median its historical median of 77.14. Over the past decade, China Healthwise Holdings' Days Payable has ranged from 44.53 to 118.83. According to the industry distribution chart, China Healthwise Holdings ranks #251 out of 609 companies in the Healthcare Providers & Services industry, placing it in the top 41.2%.
Is China Healthwise Holdings' Days Payable too high?
China Healthwise Holdings' current Days Payable of 59.75 is 23% below median its 10-year median of 77.14. Over the past 10 years, this metric has ranged from a low of 44.53 to a high of 118.83. The Healthcare Providers & Services industry median Days Payable is 57.13. China Healthwise Holdings' value of 59.75 is 4.6% above this industry median. Based on the distribution chart, China Healthwise Holdings ranks #251 out of 609 companies in the Healthcare Providers & Services industry, which is above the industry midpoint.
How does China Healthwise Holdings' Days Payable compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, China Healthwise Holdings ranks #251 out of 609 companies for Days Payable. This puts China Healthwise Holdings in the upper half of its industry. The industry median Days Payable is 57.13. China Healthwise Holdings' value of 59.75 is 4.6% above this benchmark. Historically, China Healthwise Holdings' own Days Payable has ranged from 44.53 to 118.83 over the past decade. While the company's 10-year median is 77.14 vs. the industry median of 57.13, China Healthwise Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.13, based on 609 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Healthwise Holdings's current Days Payable of 59.75 is 4.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on China Healthwise Holdings and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Healthwise Holdings's current Days Payable is 59.75, which is 23% below median its own 10-year median of 77.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Healthwise Holdings stock overvalued right now?
Based on GuruFocus' analysis, China Healthwise Holdings (HKSE:00348) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.06, compared to a current price of HK$0.09 — trading 53.3% above its estimated fair value. The current Days Payable is 59.75, which is 23% below median its 10-year median of 77.14 and 4.6% above the Healthcare Providers & Services industry median of 57.13. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For China Healthwise Holdings (HKSE:00348), the current Days Payable is 59.75 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
China Healthwise Holdings Ltd is an investment holding company. It operates in three segments: Chinese health products, Money lending business, and investment in financial instruments. The majority of its revenue comes from trading in Chinese health products, which includes, pharmaceutical products, ginseng, and dried seafood products. The company's geographical segments are Hong Kong and the PRC, of which key revenue is derived from Hong Kong.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00348 has been successfully added to your 
